Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Sandra Belalcázar-Rey, Valeria Sánchez, Juan C Ochoa-Tabares, Samuel Altamirano, Abraham Soto-Gómez, Ruben Suárez-Velasco, Filiberto García-Félix., Leopoldo Baiza-Durán, Oscar Olvera-Montaño, Patricia Muñoz-Villegas. 2019. Efficacy and safety of the PRO-087 Ophthalmic solution versus systane(R) Ultra and Systane(R) Ultra Preservative-free on the tear film dysfunction syndrome from mild to moderate.. protocols.io dx.doi.org/10.17504/protocols.io.3wvgpe6Copy Citation Copied
URL: https://dx.doi.org/10.17504/protocols.io.3wvgpe6
Authors: Sandra Belalcázar-Rey, Valeria Sánchez, Juan C Ochoa-Tabares, Samuel Altamirano, Abraham Soto-Gómez, Ruben Suárez-Velasco, Filiberto García-Félix., Leopoldo Baiza-Durán, Oscar Olvera-Montaño, Patricia Muñoz-Villegas.
Summary: The present study was designed to evaluate the efficacy of a sodium hyaluronate/chondroitin sulfate, preservative-free, ophthalmic solution (SH/CS-PF) in normalizing the parameters of the ocular surface, alleviating symptoms and in reducing the squamous metaplasia using the conjunctival impression cytology (CIC) in patients with mild-moderate dry eye disease (DED).
Affiliations: Fundación Oftalmológica Nacional, Bogotá, Colombia., Asociación para Evitar la Ceguera en Mexico IAP, CDMX, México., Private Practice, Guadalajara, Jalisco, México., Instituto Jalisciense de Metabolismo SC, Guadalajara, Jalisco, México., Catarata y Glaucoma de Occidente SA de CV, Guadalajara, Jalisco, México., Novam y Vita, Guadalajara, Jalisco, México., Private Practice, Guadalajara, Jalisco, México., Clinical Research Department, Laboratorios Sophia, SA de CV Zapopan, Jalisco, México, Clinical Research Department, Laboratorios Sophia, SA de CV Zapopan, Jalisco, México, Clinical Research Department, Laboratorios Sophia, SA de CV Zapopan, Jalisco, México
Version: 1
Publication Date: 2019
Expand AllComing soon.
Source: Protocols.io